Prospective Validation of an Eight Gene mRNA Signature in Plasma for the Diagnosis of Early Stage Lung Cancer
Por:
Capitan, AG, Rubinstein, P, Rubinstein, F, Aguilar-Hernandez, A, Bracht, J, Viteri, S, Cabrera-Galvez, C, Gonzalez-Cao, M, Moya, I, Valarezo, J, Mayo-De-Las-Casas, C, Pedraz, C, Boykin, R, Warren, S, Rosell, R and Molina, M
Publicada:
1 oct 2021
Resumen:
Filiaciones:
Capitan, AG:
Pangaea Oncol, Lab Oncol, Barcelona, Spain
Rubinstein, P:
Hosp Pilar Quironsalud, Barcelona, Spain
Rubinstein, F:
Pangaea Oncol, Lab Oncol, Barcelona, Spain
Aguilar-Hernandez, A:
Quiron Dexeus Univ Hosp, Inst Oncol Dr Rosell Ior, Barcelona, Spain
Bracht, J:
Pangaea Oncol, Lab Oncol, Barcelona, Spain
Viteri, S:
Dexeus Univ Hosp, Quironsalud Grp, Dr Rosell Oncol Inst, Barcelona, Spain
Cabrera-Galvez, C:
Quiron Dexeus Univ Hosp, Inst Oncol Dr Rosell Ior, Barcelona, Spain
Gonzalez-Cao, M:
Dexeus Univ Hosp, Quironsalud Grp, Dr Rosell Oncol Inst, Barcelona, Spain
Moya, I:
Hosp Gen Cataluna, Sant Cugat Del Valles, Spain
Valarezo, J:
Pangaea Oncol, Lab Oncol, Barcelona, Spain
Mayo-De-Las-Casas, C:
Pangaea Oncol, Lab Oncol, Barcelona, Spain
:
Inst Invest Ciencies Salut Germans Trias & Pujol, Badalona, Spain
Boykin, R:
Nanostring Technol, Seattle, AL USA
Warren, S:
Nanostring Technol, Seattle, AL USA
Rosell, R:
Dexeus Univ Hosp, Quironsalud Grp, Dr Rosell Oncol Inst, Barcelona, Spain
Molina, M:
Pangaea Oncol, Lab Oncol, Barcelona, Spain
|